Bovine Tuberculosis Diagnosis Market Size, Share, and Growth Forecast for 2025 - 2032

The global bovine tuberculosis diagnosis market is estimated to increase from US$ 802.4 Mn in 2025 to US$ 1,084.7 Mn by 2032. The market is projected to record a CAGR of 4.4% during the forecast period from 2025 to 2032.

The need for Bovine Tuberculosis (bTB) diagnostics is primarily driven by regional eradication initiatives, especially in countries striving for disease-free status. These initiatives are a component of national and international programs to defend trade interests, preserve public health, and reduce economic losses.

The government's Bovine TB Strategy in the U.K., for instance, has imposed targeted surveillance in low-risk areas. It requires yearly testing in high-risk areas at an annual cost of more than US$ 125 Mn. These steps are a part of a larger plan to prevent bTB in England by 2038. It calls for multiple diagnostic tests and the removal of affected animals.

Key Highlights of the Market

• Increasing cases of bovine tuberculosis, especially in developing countries, are driving demand for cutting-edge diagnostic tools.
• Bovine tuberculosis results in significant financial losses due to reduced milk production, low meat quality, and trade restrictions.
• Innovations, such as molecular and phage-based diagnostics, offer high sensitivity and specificity, enhancing early disease detection.
• Traditional tests like tuberculin skin tests remain widely used due to established infrastructure and cost-effectiveness.
• Increased investments by government and private organizations in disease control programs are boosting the market for bTB diagnostic tools.
• Africa and parts of Asia offer significant opportunities for diagnostic companies due to high disease prevalence and unmet needs.
• Europe will likely hold a share of 35% in 2025 amid the increasing implementation of strict animal and human safety regulations.
• Based on test type, traditional tests are anticipated to dominate with a share of 58.2% in 2025, backed by rising demand from small-scale veterinary clinics.

In 2025, Europe led the global bovine tuberculosis diagnosis market, accounting for around 35% of the total share. The region benefits from access to cutting-edge diagnostic tools, including molecular techniques. These are widely adopted due to their superior accuracy, sensitivity, and speed in detecting bovine tuberculosis.

Unique diagnostic capability is pivotal for effective disease control and management. High awareness levels among veterinary professionals and livestock producers, coupled with the availability of these technologies, continue to drive market growth in Europe.

The U.K. emerged as the leading contributor in Europe, accounting for the most prominent share in 2025. Bovine tuberculosis significantly impacts the productivity and profitability of the livestock sector, making its management a critical priority.

Trade limitations, loss of opportunities, and expenses related to the culling of infected animals underscore the need for robust diagnostic testing. Livestock producers conduct routine herd testing to prevent outbreaks and ensure the financial sustainability of their operations.

The North America bovine tuberculosis diagnosis market is projected to grow steadily in the coming years, fueled by increasing attention to animal health and the prevention of zoonotic diseases. Public health concerns, particularly the ability of bovine tuberculosis to spread from animals to humans, often through unpasteurized dairy or direct contact with infected livestock, have intensified efforts to detect and control the disease. This has led to a higher demand for accurate and timely diagnostic methods. The U.S. bovine tuberculosis diagnosis market dominated the regional market, holding the largest share of total revenue. Key contributors to this include continuous educational efforts by veterinary institutions and associations, which provide training on both traditional and advanced diagnostic approaches. These programs ensure veterinarians remain well-prepared, promoting widespread adoption and proper implementation of testing technologies throughout the industry.

The traditional tests segment is anticipated to lead the market, accounting for a 58.2% share in 2025. These tests benefit from their widespread availability and the well-established infrastructure necessary for their use.

Veterinary clinics, agricultural cooperatives, and government organizations in various regions are fully equipped to perform tuberculin skin tests, offering farmers convenient access. With existing systems for storing, handling, and administering these tests already in place, there is minimal need for further investments in new equipment or personnel training. This robust infrastructure underpins the sustained demand for traditional diagnostic methods.

The molecular diagnostic tests segment, on the other hand, is projected to witness the most significant CAGR during the forecast period. These tests help deliver enhanced sensitivity and specificity by detecting Mycobacterium Bovis at the molecular level.

Superior precision enables earlier and more accurate disease identification, which is critical in controlling the spread of bovine tuberculosis within and between herds. The reliability and accuracy of molecular diagnostics are key factors driving their increasing adoption.

The global prevalence of bovine tuberculosis is increasing, particularly in developing countries. This zoonotic disease poses significant risks to both animals and human health. As governments and health organizations enhance control measures, there is a growing demand for fast and reliable diagnostic tools, fueling market expansion.

Bovine tuberculosis poses a significant challenge to the dairy and meat sectors, which are considered key contributors to agricultural economies worldwide. Infected cattle often experience decreased milk production and low meat quality, resulting in financial losses for farmers.

Outbreaks also trigger trade restrictions and erode consumer confidence. These further prompt dairy and meat producers to invest in preventive measures, such as regular testing to protect livestock and maintain product standards, thereby driving demand for bovine tuberculosis diagnostics.

Growth of veterinary healthcare infrastructure, especially in developing regions, further boosts the market. Enhanced access to veterinary services as well as the establishment of specialized animal health clinics and diagnostic labs improves the efficiency and reach of diagnosis. As these infrastructures advance, the adoption of innovative diagnostic tools is anticipated to surge, supporting market development.

From 2019 to 2024, the bovine tuberculosis diagnosis market witnessed an average CAGR of 3.8%. It was driven by increasing disease prevalence and rising awareness globally. Traditional diagnostic tests, such as tuberculin skin tests, continued to dominate the market due to their widespread availability and established infrastructure.

Growing demand for highly precise and early detection methods, however, led to the rising adoption of molecular diagnostic tools, including PCR-based tests. The market also saw a surge in investments in veterinary healthcare infrastructure, especially in developing regions like Africa and parts of Asia, bovine tuberculosis remained a significant threat. Growing economic impact of the disease, coupled with its zoonotic transmission risks, further pushed demand for reliable diagnostic solutions, benefiting key market players.

In the forecast period, the market is anticipated to continue its upward trajectory, with molecular diagnostic tests witnessing a significant growth rate. Innovations like phage-based diagnostics and AI-driven tools are set to further enhance early disease detection, improving market penetration.

Government regulations focusing on disease control and rising investments in animal health infrastructure, particularly in emerging economies, will likely fuel market expansion. As the dairy and meat industries seek to mitigate economic losses and ensure product quality, demand for regular testing and reliable diagnostics is projected to increase. The market is set for significant growth driven by technological developments, surging veterinary infrastructure, and rising disease awareness.

Outbreak of Bovine Tuberculosis to Push Demand Worldwide

The bovine tuberculosis diagnosis market is driven by several key factors contributing to its sustained growth. A leading driver is the increasing prevalence of Bovine Tuberculosis (bTB) globally, particularly in developing regions like Africa and Asia. There, disease rates remain alarmingly high.

Rising prevalence surges the demand for effective diagnostic tools to prevent outbreaks and ensure livestock health. Technological developments in diagnostic methods also play a key role in market growth.

Innovations such as molecular diagnostics, including PCR-based and phage-based tools, provide greater sensitivity and specificity. These enable early and accurate detection of Mycobacterium Bovis. These developments are particularly critical for preventing disease spread and reducing economic losses for farmers and livestock producers.

Implementation of Stringent Norms on Livestock Trade to Fuel Demand

Increased need for Bovine Tuberculosis (bTB) detection is mainly due to strict laws controlling the cattle trade. Stringent health regulations are enforced in countries with low or moderate bTB prevalence to guarantee disease-free certification. This is essential for preserving access to profitable export markets.

• To certify herds as officially free from bTB, for instance, the European Union (EU) mandates that member states follow the EU Animal Health Law (Regulation 2016/429), which calls for regular bTB testing and eradication campaigns. This rule immediately promotes exports to international markets as well as trade within the EU.
• Likewise, under the National Tuberculosis Eradication Program, the U.S. Department of Agriculture (USDA) requires bTB-free accreditation for foreign exports and interstate cattle transportation.

The regulations have a substantial economic impact. Global beef and veal commerce alone was worth around US$ 60 Bn in 2023, with the U.S., Brazil, and Australia leading the export market. These countries maintain their competitive advantage due to disease-free certification. For instance,

Strict bTB surveillance and testing procedures are necessary as Australia's livestock export industry, which generates over AUD 23 Bn a year, mostly depends on its reputation as a disease-free country.

High Costs of Unique Diagnostic Tools to Hamper Demand

The bovine tuberculosis diagnosis market faces certain challenges that hinder its growth. High costs associated with unique diagnostic tools, such as molecular tests, limit their adoption, especially in developing regions. Limited access to veterinary healthcare infrastructure in rural areas further restricts widespread testing and diagnosis.

The lack of standardized diagnostic protocols globally creates inconsistencies in disease detection and reporting. Resistance from livestock producers to regular testing due to financial constraints also impedes market expansion. Furthermore, the complexity of diagnosing latent infections and the need for specialized training to use novel diagnostic tools add to operational hurdles in the market.

Surging Prevalence of Bovine Tuberculosis in Emerging Countries Forges Avenues

The high prevalence of Bovine Tuberculosis (bTB) presents a significant opportunity in the bovine diagnostics business. This chronic infectious disease primarily affects cattle and can spread to other animals and humans. For instance,

• Recognized as a notifiable disease by the World Organization for Animal Health (WOAH), bTB requires prompt detection and reporting. According to a May 2023 report by Thermo Fisher Scientific, over 50 million cattle worldwide are impacted by bTB, leading to annual economic losses estimated at approximately US$ 3 Bn. In the U.K. alone, the financial burden of bTB amounts to nearly US$ 145 Mn each year.

The incidence of bTB varies across regions. While it is relatively rare in Canada, Europe, and the U.S., prevalence rates reach around 50% in parts of Africa and Asia. Despite ongoing developments in technology and infrastructure, various emerging nations face challenges in effectively diagnosing bTB. This is mainly due to its complexity and the absence of standardized diagnostic strategies.

The situation creates opportunities for market players to extend their presence. They aim to raise awareness and develop products tailored to the specific socioeconomic conditions of countries in Africa and Asia.

The global bovine tuberculosis diagnosis industry is marked by intense competition, with key players focusing on innovation and strategic collaborations to gain an edge. Leading companies, including Thermo Fisher Scientific, IDEXX Laboratories, and Zoetis, are investing in unique diagnostic technologies, such as molecular and phage-based diagnostics.

Regional and niche players are strengthening their presence by developing cost-effective solutions tailored to local needs, particularly in emerging markets. Collaborations with veterinary institutions and research organizations are common strategies to enhance product efficacy and reach. The market also witnesses strong competition in traditional testing segments due to established infrastructure and widespread adoption.

Recent Development in the Bovine Tuberculosis Diagnosis Market

In July 2023, PBD Biotech, based in the U.K., and Actiphage TB commenced their third clinical trial. This innovative phase-based molecular diagnostic is being developed in collaboration with PBD Biotech, the NIHR Respiratory Biomedical Research Centre in Leicester (UK), and the University of Leicester. The study focuses on validating the diagnostic test’s effectiveness for tuberculosis detection, with the potential to monitor TB progression.